TNKASE (tenecteplase) - Roche, Boehringer Ingelheim
Tenecteplase for Acute Ischemic Stroke Within 4.5 to 6 Hours of Onset (EXIT-BT2) (clinicaltrials.gov) - Sep 11, 2026 - P4 | N=1440 | Recruiting | Sponsor: General Hospital of Shenyang Military Region | Trial completion date: Dec 2026 ➔ Dec 2029 | Trial primary completion date: Dec 2026 ➔ Dec 2029 
Trial completion date • Trial primary completion date • Cardiovascular • Ischemic stroke
http://clinicaltrials.gov/ct2/show/NCT06010628
 
Sep 11, 2026
 
Prev Next